Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8650887 | American Heart Journal | 2018 | 19 Pages |
Abstract
In a large US-based outpatient registry, we found that a quarter of adults with T2D had a diagnosis of HF, which was predominantly HFpEF. Although certain T2D medication use in patients with HF appeared consistent with evidence (less use of thiazolidinediones), others appeared contrary to evidence (less use of metformin and SGLT2 inhibitors).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Suzanne V. MD MHA, Justin B. MD PhD, Carolyn SP MBBS PhD, Silvio E MD, Fengming MS, Darren K MD MHSc, Abhinav MD MHS, Thomas M MD MSc, Laurence S MD, Gregg C MD, Frederick A MD MSPH, Mikhail MD,